Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,081,065
+$16,503,716 QoQ
Shares Held
564,398
+17.8% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#53
of 477 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVENTIDE ASSET MANAGEMENT, LLC holds $1,774,593,873 across 55 Biotechnology names. CYTK ranks #13 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,248,389 | $146,148,900 | |
| 2 | ARGX |
Argenx SE
|
125,668 | $116,591,000 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
2,111,410 | $116,127,550 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
1,380,219 | $80,232,130 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
316,820 | $77,548,031 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,380,261 | $77,391,234 | |
| 7 | INSM |
INSMED Inc
|
583,665 | $62,230,362 | |
| 8 | BLTE |
Belite Bio, Inc
|
390,829 | $60,181,803 |
All Filings in CYTK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,081,065 | 564,398 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $31,577,349 | 479,098 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,474,482 | 479,611 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,349,135 | 170,108 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,243,480 | 249,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,380,552 | 382,696 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,955,121 | 254,148 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,419,014 | 254,148 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,769,738 | 254,148 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $17,818,316 | 254,148 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $46,420,440 | 556,000 | Shares | Sole | 2024-02-20 | |
| 2023-09-30 | $16,379,760 | 556,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,136,720 | 556,000 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $19,565,640 | 556,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $25,475,920 | 556,000 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||